Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


ARCH Venture Fund VII, L.P. Create: Alert

All | News | Filings
Date FiledTypeDescription
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/08/2022 SC 13G/A ARCH Venture Fund VII, L.P. has filed a Schedule 13D for 908 Devices, Inc.
02/04/2021 SC 13G ARCH Venture Fund VII, L.P. has filed a Schedule 13D for * 908 Devices Inc.
02/02/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/02/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/02/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/22/2020 4 ARCH Venture Fund VII, L.P. (10% Owner) has filed a Form 4 on 908 Devices Inc.
Txns: Converted 5,425,045 shares @ $0
Bought 300,000 shares @ $20, valued at $6M
Converted 2,927,386 preferred shares @ $0
Converted 981,443 preferred shares @ $0
Converted 669,977 preferred shares @ $0
Converted 665,661 preferred shares @ $0
Converted 180,578 preferred shares @ $0
12/17/2020 3 ARCH Venture Fund VII, L.P. (10% Owner) has filed a Form 3 on 908 Devices Inc.
02/14/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2020 SC 13G/A Arch Venture Fund VII LP reports a 21.9% stake in Unity Biotechnology, Inc.
02/13/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
07/25/2019 SC 13D/A Arch Venture Fund VII LP has filed a Schedule 13D for Pulmatrix, Inc.
07/17/2019 4 ARCH Venture Fund VII, L.P. (10% Owner) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Sold 2,700 shares @ $8.2651, valued at $22.3k
Sold 25,779 shares @ $7.8078, valued at $201.3k
Sold 34,521 shares @ $7.6964, valued at $265.7k
03/22/2019 SC 13D/A Arch Venture Fund VII LP reports a 5.6% stake in Pulmatrix, Inc.
03/14/2019 4 ARCH Venture Fund VII, L.P. (10% Owner) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Sold 40,092 shares @ $7.3674, valued at $295.4k
Sold 81,591 shares @ $7.8862, valued at $643.4k
Sold 2,820 shares @ $8.1993, valued at $23.1k
Sold 43,000 shares @ $8.1498, valued at $350.4k
03/11/2019 4 ARCH Venture Fund VII, L.P. (10% Owner) has filed a Form 4 on Syros Pharmaceuticals, Inc.
Txns: Sold 35,209 shares @ $6.8736, valued at $242k
Sold 84,496 shares @ $6.9266, valued at $585.3k
Sold 44,878 shares @ $6.4924, valued at $291.4k
02/14/2019 SC 13G Arch Venture Fund VII LP reports a 23.7% stake in Unity Biotechnology, Inc.
02/14/2019 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/14/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/06/2018 4 ARCH Venture Partners VIII, LLC (10% Owner) has filed a Form 4 on Twist Bioscience Corp
Txns: Converted 1,182,645 shares @ $0
Converted 718,275 shares @ $0
Converted 266,776 shares @ $0
Converted 224,726 shares @ $0
Bought 15,000 shares @ $14, valued at $210k
Converted 894,146 shares @ $0
Bought 60,000 shares @ $14, valued at $840k
Converted 1,182,645 preferred shares @ $0
Converted 718,275 preferred shares @ $0
Converted 266,776 preferred shares @ $0
Converted 224,726 preferred shares @ $0
10/30/2018 3 ARCH Venture Partners VIII, LLC (10% Owner) has filed a Form 3 on Twist Bioscience Corp
05/07/2018 4 ARCH Venture Partners VII, LLC (10% Owner) has filed a Form 4 on Unity Biotechnology, Inc.
Txns: Converted 2,030,625 shares @ $0
Converted 4,228,432 shares @ $0
Converted 2,067,160 shares @ $0
Converted 1,486,745 shares @ $0
Converted 195,672 shares @ $0
Converted 2,030,625 preferred shares @ $0
Converted 4,228,432 preferred shares @ $0
Converted 2,067,160 preferred shares @ $0
Converted 1,486,745 preferred shares @ $0
Converted 195,672 preferred shares @ $0
05/03/2018 3 ARCH Venture Partners VII, LLC (10% Owner) has filed a Form 3 on Unity Biotechnology, Inc.
04/12/2018 4 Arch Venture Fund VII LP (Former 10% Owner) has filed a Form 4 on Pulmatrix, Inc.
04/12/2018 SC 13D/A Arch Venture Fund VII LP reports a 9.9% stake in Pulmatrix, Inc.
04/05/2018 4 GILLIS STEVEN (Director) has filed a Form 4 on Pulmatrix, Inc.
Txns: Bought 1,150,000 shares @ $0
Bought 1,150,000 options to buy @ $0.65, valued at $747.5k
Bought 1,150,000 options to buy @ $0.75, valued at $862.5k
03/09/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/02/2018 SC 13G/A Arch Venture Fund VII LP reports a 17.7% stake in Syros Pharmaceuticals, Inc.
02/02/2018 SC 13G/A Arch Venture Fund VII LP reports a 9.3% stake in Juno Therapeutics, Inc.
01/05/2018 SC 13D/A Arch Venture Fund VII LP reports a 10.9% stake in Pulmatrix, Inc.
02/14/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/13/2017 SC 13G/A Juno Therapeutics, Inc. reports a 10% stake in Juno Therapeutics, Inc.
02/13/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy